These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35024704)
1. Osmium(VI) nitride triggers mitochondria-induced oncosis and apoptosis. Ye M; Huang WQ; Li ZX; Wang CX; Liu T; Chen Y; Hor CH; Man WL; Ni WX Chem Commun (Camb); 2022 Feb; 58(15):2468-2471. PubMed ID: 35024704 [TBL] [Abstract][Full Text] [Related]
2. A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells. Huang WQ; Wang CX; Liu T; Li ZX; Pan C; Chen YZ; Lian X; Man WL; Ni WX Dalton Trans; 2020 Dec; 49(47):17173-17182. PubMed ID: 33119012 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands. Tang Q; Ni WX; Leung CF; Man WL; Lau KK; Liang Y; Lam YW; Wong WY; Peng SM; Liu GJ; Lau TC Chem Commun (Camb); 2013 Nov; 49(85):9980-2. PubMed ID: 24042270 [TBL] [Abstract][Full Text] [Related]
4. Photoactivated Osmium Arene Anticancer Complexes. Xue X; Fu Y; He L; Salassa L; He LF; Hao YY; Koh MJ; Soulié C; Needham RJ; Habtemariam A; Garino C; Lomachenko KA; Su Z; Qian Y; Paterson MJ; Mao ZW; Liu HK; Sadler PJ Inorg Chem; 2021 Dec; 60(23):17450-17461. PubMed ID: 34503331 [TBL] [Abstract][Full Text] [Related]
6. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles. Novak MS; Büchel GE; Keppler BK; Jakupec MA J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253 [TBL] [Abstract][Full Text] [Related]
7. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells. Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527 [TBL] [Abstract][Full Text] [Related]
8. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex. Suntharalingam K; Lin W; Johnstone TC; Bruno PM; Zheng YR; Hemann MT; Lippard SJ J Am Chem Soc; 2014 Oct; 136(41):14413-6. PubMed ID: 25247635 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes. Marloye M; Inam H; Moore CJ; Debaille V; Pritchard JR; Gelbcke M; Meyer F; Dufrasne F; Berger G J Biol Inorg Chem; 2021 Aug; 26(5):535-549. PubMed ID: 34173882 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Thioredoxin Reductase by Triosmium Carbonyl Clusters. Koh WX; Coppo L; Holmgren A; Kong JW; Leong WK Chem Res Toxicol; 2020 Sep; 33(9):2441-2445. PubMed ID: 32786549 [TBL] [Abstract][Full Text] [Related]
11. Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways. Suntharalingam K; Johnstone TC; Bruno PM; Lin W; Hemann MT; Lippard SJ J Am Chem Soc; 2013 Sep; 135(38):14060-3. PubMed ID: 24041161 [TBL] [Abstract][Full Text] [Related]
12. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates. Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583 [TBL] [Abstract][Full Text] [Related]
14. A Pyrazolate Osmium(VI) Nitride Exhibits Anticancer Activity through Modulating Protein Homeostasis in HepG2 Cells. Huang C; Huang W; Ji P; Song F; Liu T; Li M; Guo H; Huang Y; Yu C; Wang C; Ni W Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361570 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
16. Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs. Arion VB; Dobrov A; Göschl S; Jakupec MA; Keppler BK; Rapta P Chem Commun (Camb); 2012 Sep; 48(68):8559-61. PubMed ID: 22797078 [TBL] [Abstract][Full Text] [Related]
17. In-cell Catalysis by Tethered Organo-Osmium Complexes Generates Selectivity for Breast Cancer Cells. Coverdale JPC; Bedford RA; Carter OWL; Cao S; Wills M; Sadler PJ Chembiochem; 2024 Aug; 25(15):e202400374. PubMed ID: 38785030 [TBL] [Abstract][Full Text] [Related]
18. Novel gold-based complex GC7 suppresses cancer cell proliferation via impacting energy metabolism mediated by mitochondria. Cui Q; Ding W; Luo B; Lu W; Huang P; Wen S Bioorg Med Chem; 2024 Oct; 112():117897. PubMed ID: 39216383 [TBL] [Abstract][Full Text] [Related]
19. Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes. Zhang P; Huang H Dalton Trans; 2018 Oct; 47(42):14841-14854. PubMed ID: 30325378 [TBL] [Abstract][Full Text] [Related]
20. Mitochondria-localizing dicarbohydrazide Ln complexes and their mechanism of in vitro anticancer activity. Meng T; Liu T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP Dalton Trans; 2020 Apr; 49(14):4404-4415. PubMed ID: 32175553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]